BackMera Pharmaceuticals Overview

Mera Pharmaceuticals Receivables

Mera Pharmaceuticals's receivables is $7.8K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$7848.00
↓ 11.46% YoYΔ $-1016.00 vs prior year quarter

Peer trimmed avg / median

Loading

Mera Pharmaceuticals Receivables History

Loading

Mera Pharmaceuticals vs. peers: Receivables Comparison

Loading

Mera Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Mera Pharmaceuticals (MRPI) FAQ

Mera Pharmaceuticals posts a receivables of $7.8K as of October 2011. That compares with $8.9K in the prior-year period — down 11.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Mera Pharmaceuticals's receivables was $8.9K. The latest reading is $7.8K — a 11.5% year-over-year decrease (period ending October 2011). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Mera Pharmaceuticals's financial statement story. At $7.8K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for MRPI's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Mera Pharmaceuticals's other metric pages and overview cover the third.

Judging Mera Pharmaceuticals against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in receivables easier to interpret. Start with $7.8K here, then scan peer and history charts to see if the gap is persistent.